 PRINCETON, NJ ACCESSWIRE March 29, 2021 Sonnet BioTherapeutics Holdings, Inc. NASDAQ:SONN Sonnet or the Company, a biopharmaceutical company developing innovative targeted biologic drugs, announced today a business update on its ongoing programs. Last year we continued execution across our pipeline, and I am excited to share an update on our ongoing activities, commented Pankaj Mohan, Ph.D. 